These components acted to protect mice against colitis inflammation by significantly suppressing cytokines [γ‐interferon (IFNγ), IL‐6,IL‐1β, and IL‐17a] related to colitis pathology and upregulating anti‐inflammatory cytokine IL‐10 (Eichenberger et al., 2018a). Here, IL17A is linked to colitis.